Mashukur Rahman/LinkedIn
Feb 8, 2026, 14:09
Mashukur Rahman: New ESC Dyslipidemia Updates Expand the Role of Statins
Mashukur Rahman, Resident Doctor at Bangladesh Medical University, Medical Officer at Directorate General of Health Services, shared a post on LinkedIn.
“Many doctors still think statins are only for high LDL cholesterol.
But the new ESC dyslipidemia updates suggest a bigger role.
Why this matters now:
- Statins may help protect the heart in some cancer patients.
Some chemotherapy drugs like anthracyclines can cause heart failure years later. Preventive statin use is getting stronger support. - We are moving from treating numbers to treating overall risk.
Risk builds silently, even when LDL is not very high.
In real life, we often wait for LDL to cross a ‘clear cutoff.’
But by then, damage may already be starting.
If statins are becoming broader heart-protection drugs — when should we start them in borderline-risk patients?”
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke